Solubility measurement of verapamil for the preparation of developed nanomedicines using supercritical fluid

A static method is employed to determine the solubilities of verapamil in supercritical carbon dioxide (SC-CO(2)) at temperatures between 308 and 338 K and pressures between 12 and 30 MPa. The solubility of verapamil in SC-CO(2) expressed as mole fraction are in the range of 3.6 × 10(–6) to 7.14 × 10(–5). Using four semi-empirical density-based models, the solubility data are correlated: Chrastil, Bartle, Kumar–Johnston (K–J), and Mendez-Santiago and Teja (MST), two equations of state (SRK and PC-SAFT EoS), expanded liquid models (modified Wilson's models), and regular solution model. The obtained results indicated that the regular solution and PC-SAFT models showed the most noteworthy exactness with AARD% of 1.68 and 7.45, respectively. The total heat, vaporization heat, and solvation heat of verapamil are calculated at 39.62, 60.03, and − 20.41 kJ/mol, respectively. Regarding the poor solubility of verapamil in SC-CO(2), supercritical anti-solvent methods can be an appropriate choice to produce fine particles of this drug.